ATE293367T1 - Nahrungszusammensetzungen enthaltend methionin - Google Patents

Nahrungszusammensetzungen enthaltend methionin

Info

Publication number
ATE293367T1
ATE293367T1 AT98935394T AT98935394T ATE293367T1 AT E293367 T1 ATE293367 T1 AT E293367T1 AT 98935394 T AT98935394 T AT 98935394T AT 98935394 T AT98935394 T AT 98935394T AT E293367 T1 ATE293367 T1 AT E293367T1
Authority
AT
Austria
Prior art keywords
carbohydrates
compositions containing
food compositions
containing methionine
methionine
Prior art date
Application number
AT98935394T
Other languages
English (en)
Inventor
Robert Johan Joseph Hageman
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8228562&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE293367(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Application granted granted Critical
Publication of ATE293367T1 publication Critical patent/ATE293367T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
AT98935394T 1997-07-14 1998-07-14 Nahrungszusammensetzungen enthaltend methionin ATE293367T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97202206A EP0891719A1 (de) 1997-07-14 1997-07-14 Narungszusammensetzungen mit Gehalt an Methionin
PCT/NL1998/000408 WO1999003365A1 (en) 1997-07-14 1998-07-14 Nutritional composition containing methionine

Publications (1)

Publication Number Publication Date
ATE293367T1 true ATE293367T1 (de) 2005-05-15

Family

ID=8228562

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98935394T ATE293367T1 (de) 1997-07-14 1998-07-14 Nahrungszusammensetzungen enthaltend methionin

Country Status (9)

Country Link
US (1) US6544547B2 (de)
EP (2) EP0891719A1 (de)
JP (1) JP2001510145A (de)
AT (1) ATE293367T1 (de)
AU (1) AU8465898A (de)
DE (1) DE69829853T2 (de)
DK (1) DK1001685T3 (de)
HK (1) HK1028324A1 (de)
WO (1) WO1999003365A1 (de)

Families Citing this family (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19817877C2 (de) * 1998-04-22 2002-06-13 Hans Guenter Berner Energy-Drink auf Fruchtsaftbasis
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
ES2198067T3 (es) * 1998-07-28 2004-01-16 Synthes Ag Chur Utilizacion de compuestos a base de creatina para tratar las celulas y los tejidos oseos y cartilaginosos.
DE19856789A1 (de) 1998-12-09 2000-06-15 Nutricia Nv Thymuswachstumsstimulierende Säuglingsnahrung
EP0951842B1 (de) 1999-01-20 2002-12-04 N.V. Nutricia Säuglingsnährpräparat
DE50010583D1 (de) * 1999-01-29 2005-07-28 Sportmedizin Team Vertriebs Gm Zusammensetzung zur Leistungsförderung bei sportlicher Tätigkeit, ihre Herstellung und Verwendung als diätetisches Lebensmittel
ES2250112T3 (es) 1999-03-08 2006-04-16 Medicure Inc. Analogos de piridoxal para el tratamiento de trastornos causados por carencia de vitamina b6.
FR2791571B1 (fr) * 1999-04-02 2002-10-04 Sod Conseils Rech Applic Association inhibiteur(s) de no synthase et antioxydant(s) metabolique(s)
EP1196047A4 (de) * 1999-06-29 2004-12-22 New Zealand Milk Inst Ltd Vorbeugender dietaetischer lebensmittelzusatz auf basis von milch
CA2376029A1 (en) 1999-07-13 2001-01-18 Medicure Inc. Use of pyridoxin derivatives for the treatment of diabetes and related complications
IT1306173B1 (it) * 1999-07-23 2001-05-30 Sigma Tau Healthscience Spa Composizione per la prevenzione degli affaticamenti muscolari e permigliorare il rendimento energetico muscolare.
WO2001013900A2 (en) 1999-08-24 2001-03-01 Medicure International Inc. Compositions for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds
US6479545B1 (en) * 1999-09-30 2002-11-12 Drugtech Corporation Formulation for menopausal women
WO2001056572A1 (en) * 2000-02-02 2001-08-09 Metagenics, Inc. Compositions and methods for promoting healthy joints
US8642581B1 (en) * 2000-02-11 2014-02-04 Brian D. Halevie-Goldman Compositions and methods for the production of S-adenosylmethionine within the body
ATE293119T1 (de) 2000-02-29 2005-04-15 Medicure Int Inc Cardioprotektive phosphonate
AU784840B2 (en) 2000-03-28 2006-07-06 Medicure International Inc. Treatment of cerebrovascular disease
CN1423528A (zh) 2000-04-18 2003-06-11 雀巢制品公司 营养单元
US7226916B1 (en) 2000-05-08 2007-06-05 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
US7208180B2 (en) 2000-05-08 2007-04-24 N.V. Nutricia Method and preparation for the preventing and/or treating vascular disorders and secondary disorders associated therewith
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US6576634B1 (en) * 2000-07-07 2003-06-10 N.V. Nutricia Pharmaceutical or dietetic preparation for improvement of fertility and sperm quality
EP1299358B1 (de) 2000-07-07 2007-06-13 Medicure International Inc. Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
AU2000265516A1 (en) * 2000-08-11 2002-02-25 The Lawson Health Research Institute Compositions and methods for inhibiting islet dysfunction and autoimmune disorders
US6423349B1 (en) * 2000-08-24 2002-07-23 Baxter International, Inc. Therapeutic nutrient composition for pre and post elective surgery
US6579904B1 (en) 2000-09-22 2003-06-17 K.E.R. Associates, Inc. Process for making betaine transition metal complexes for use in animal feed supplements and compositions thereof
US7696219B2 (en) 2000-09-27 2010-04-13 Everett Laboratories, Inc. Method and composition for supplementation of nutritional deficiences in renal patients
US6995166B1 (en) * 2000-09-27 2006-02-07 Everett Laboratories, Inc. Method and composition for supplementation of nutritional deficiencies in renal patients
DE10057290B4 (de) * 2000-11-17 2004-01-08 Fresenius Kabi Deutschland Gmbh Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten
WO2002043507A2 (en) * 2000-11-30 2002-06-06 The Health Research Institute Nutrient supplements and methods for treating autism and for preventing the onset of autism
US6716466B2 (en) * 2001-01-17 2004-04-06 Nestec S.A. Balanced food powder composition
US20020176881A1 (en) * 2001-01-26 2002-11-28 George Verlaan Rehydration composition
CA2445512C (en) * 2001-04-25 2010-10-12 Cobalz Limited A method for treating or preventing a functional vitamin b12 deficiency in an individual and medical compositions for use in said method
US6660293B2 (en) 2001-06-29 2003-12-09 Everett Laboratories, Inc. Compositions and methods for prophylactic and therapeutic supplementation of nutrition in subjects
US7560123B2 (en) 2004-08-12 2009-07-14 Everett Laboratories, Inc. Compositions and methods for nutrition supplementation
GB2381451A (en) * 2001-11-01 2003-05-07 New Technology Res Ltd Pharmaco-dietary preparation having nutrition-supplementing and nutrition-enhancing effect
NL1019368C2 (nl) 2001-11-14 2003-05-20 Nutricia Nv Preparaat voor het verbeteren van receptorwerking.
EP1327443A1 (de) * 2001-12-21 2003-07-16 Kyowa Hakko Kogyo Co., Ltd. Wirkstoffe zur Behandlung oder Prävention von Krankheiten, die durch eine reduzierte Expression des Klotho-Proteins verursacht wurden
AU2003247224A1 (en) * 2002-06-19 2004-01-06 N.V. Nutricia Nutritional or pharmaceutical compositions for increasing the creatine response of organisms
EP3184107A1 (de) * 2002-06-19 2017-06-28 N.V. Nutricia Verfahren und zubereitung zur behandlung von metabolischem stress
US20040162292A1 (en) * 2002-12-03 2004-08-19 Evenstad Kenneth L. Multivitamin formulations for promoting healthy collagen, and methods of their use
JP2004203863A (ja) * 2002-12-09 2004-07-22 Taisho Pharmaceut Co Ltd 抗糖尿病用組成物
US6814983B2 (en) 2002-12-10 2004-11-09 Everett Laboratories, Inc. Compositions and methods for nutrition supplementation
US8617617B2 (en) 2002-12-10 2013-12-31 Everett Laboratories, Inc. Methods and kits for co-administration of nutritional supplements
EP1617734A1 (de) * 2003-04-17 2006-01-25 Boehringer Ingelheim International GmbH Multivitamin- und mineralstoffergänzung für schwangere
US20050013884A1 (en) * 2003-07-16 2005-01-20 Rennels M. Scott Compositions and methods for treating heart disease
US8173618B2 (en) * 2003-07-25 2012-05-08 University Of Massachusetts Formulations for reducing neuronal degeneration
DE10340845A1 (de) * 2003-09-04 2005-03-31 Flavin-Koenig, Dana F., Dr. Pharmazeutisches Kombinationspräparat, enthaltend Glycyrrhizinsäure, Zink und eine Verbindung, die eine Thiolgruppe oder eine zu dieser metabolisierbare Gruppe enthält
EP1675480B1 (de) * 2003-10-16 2018-06-13 Nestec S.A. Nahrhafte zusammensetzung gegen die nebenwirkungen von chemotherapie oder strahlentherapie
US8377904B2 (en) * 2004-02-09 2013-02-19 Hill's Pet Nutrition, Inc. Composition and method for use in cartilage affecting conditions
US20070043054A1 (en) * 2004-03-15 2007-02-22 Howard James R Enzyme cofactor combination for supplementing pyruvate dehydrogenase and alpha ketogluterate dehydrogenase complexes
EP1730522A2 (de) * 2004-03-29 2006-12-13 Howard Murad Verfahren zur behandlung von dermatologischen erkrankungen
NZ550418A (en) * 2004-04-09 2009-06-26 Nutricia Nv Liquid concentrated formula
AU2005259735A1 (en) * 2004-07-07 2006-01-12 Medicure International Inc. Combination therapies employing platelet aggregation drugs
US8101587B2 (en) 2004-08-12 2012-01-24 Everett Laboratories, Inc. Kits for nutrition supplementation
DE102004041270A1 (de) 2004-08-26 2006-03-02 Merz Pharma Gmbh & Co. Kgaa Ein Kapillar- Wirksystem enthaltende Zusammensetzungen mit anwendungsbezogener Differenzierbarkeit und deren Verwendung
KR101217263B1 (ko) * 2004-08-27 2012-12-31 재단법인서울대학교산학협력재단 시스테인 또는 메타이오닌을 포함하는 갭 결합을 통한세포간 정보전달 억제 예방 및 치료용 조성물
US7459468B2 (en) * 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
US20060094749A1 (en) * 2004-10-28 2006-05-04 Medicure International Inc. Substituted pyridoxines as anti-platelet agents
AU2005304220A1 (en) 2004-10-28 2006-05-18 Medicure International Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
US20060110501A1 (en) * 2004-11-22 2006-05-25 Axelrod Glen S Vaccinium injection molding
US20060135610A1 (en) * 2004-12-22 2006-06-22 Bortz Jonathan D Cardiovascular compositions
AU2005322887B2 (en) * 2004-12-30 2010-03-11 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
US8252742B2 (en) 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
US20080138483A1 (en) * 2005-02-09 2008-06-12 Kevin Meehan Animal feed composition for increased bioactivity and production of glutathione peroxidase and superoxide dismutase
US9095164B2 (en) * 2005-02-09 2015-08-04 Kevin Meehan Animal feed composition for increased production of glutathione peroxidase and superoxide dismutase
CA2537452C (en) * 2005-03-09 2013-12-24 Abbott Laboratories Concentrated human milk fortifier liquid
AU2006263652B2 (en) 2005-06-29 2010-06-17 Hill's Pet Nutrition, Inc. Methods and compositions for the prevention and treatment of inflammatory disease
DE102005037298A1 (de) * 2005-08-08 2007-03-08 Christine Jaschek Verwendung von Kalium-, Magnesium-, Calcium- und Zink-Elektrolyten zur Behandlung des Elementemangel- und Austrocknungssyndroms Alzheimer und anderer Demenzen
CA2620366C (en) * 2005-08-26 2014-04-01 Nestec S.A. Nutrition for obese patients
AU2006317440A1 (en) * 2005-11-28 2007-05-31 Medicure International Inc. Selected dosage for the treatment of cardiovascular and related pathologies
WO2007064871A2 (en) * 2005-12-02 2007-06-07 Howard Murad Diagnostic and treatment regimen for achieving body water homeostasis
ATE509624T1 (de) 2005-12-23 2011-06-15 Nutricia Nv Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
AU2007233318B2 (en) * 2006-04-04 2011-06-02 Hill's Pet Nutrition, Inc. Compositions and methods for enhancing the antioxidant status of animals
US20070292529A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating osteoporotic conditions
US20070292535A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating arthritic and or osteoporitic conditions
WO2009002146A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Supporting activities of daily living
WO2009002145A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Lipid composition for improving function of brain functioning
US20090104171A1 (en) * 2007-10-19 2009-04-23 Pardee Joel D Metabolic Enhancement Therapy
US8597640B2 (en) * 2007-10-31 2013-12-03 University Of Massachusetts Lowell Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging
WO2009066562A1 (ja) * 2007-11-20 2009-05-28 Meiji Dairies Corporation 赤血球系幹細胞の分化促進剤及び／又は増殖促進剤、並びに老人性貧血を防止又は治療するためのメチオニンの使用及びメチオニンを含む組成物
PL2222311T3 (pl) 2007-12-20 2013-08-30 Nutricia Nv Ciekły produkt zawierający nukleotydy/nukleozydy
CA2749401C (en) * 2009-01-19 2016-07-26 Nutri Co., Ltd. Low-concentration nutritional composition
JP5682118B2 (ja) * 2009-02-17 2015-03-11 大正製薬株式会社 葉酸含有飲料
ES2569922T3 (es) 2009-11-25 2016-05-13 Nestec S.A. Composiciones nutritivas, que incluyen un componente de alto contenido en proteínas y nucleótidos exógenos
CA2825428C (en) * 2010-02-12 2022-06-14 Alexander Vuckovic, M.D., Llc Compositions and methods for treating depression
FR2993780B1 (fr) * 2012-07-26 2015-02-13 Assist Publ Hopitaux De Paris Methode de traitement de la sclerose en plaque
IT1402330B1 (it) * 2010-09-03 2013-08-30 Poli Integratore alimentare
CA2815812C (en) 2010-11-02 2018-10-23 Abbott Laboratories Stable concentrated liquid human milk fortifier
TWI561175B (en) * 2011-03-31 2016-12-11 Meiji Co Ltd Flowable nutrition composition containing l-arginine and method for producing the same
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
JP5997425B2 (ja) * 2011-08-18 2016-09-28 協和発酵バイオ株式会社 オルニチン含有組成物
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
JP2014159381A (ja) * 2013-02-19 2014-09-04 Kyowa Hakko Bio Co Ltd オルニチン含有体組成改善用組成物
BR112017023956A2 (pt) * 2015-06-08 2018-07-17 Halliburton Energy Services, Inc. método para perfurar em uma formação subterrânea e sistema de perfuração
WO2017059895A1 (en) * 2015-10-07 2017-04-13 Parthenogen Sagl Dietary supplementation to achieve oxy-redox homeostasis and genomic stability
CA3042699A1 (en) 2016-11-03 2018-08-09 Alexander Vuckovic, M.D., Llc Compositions and methods for treating depression
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
KR20200039748A (ko) 2017-08-14 2020-04-16 악셀라 헬스 인크. 간 질환 치료를 위한 아미노산 조성물
CN112823018A (zh) 2018-06-20 2021-05-18 胺细拉健康公司 制备氨基酸组合物的方法
EP3810123A1 (de) 2018-06-20 2021-04-28 Axcella Health Inc. Zusammensetzungen und verfahren zur behandlung von fettinfiltration in muskeln
WO2021035060A1 (en) * 2019-08-21 2021-02-25 Brain Chemistry Labs Compositions comprising a metal and l-serine, and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4543262A (en) * 1983-03-30 1985-09-24 Nabisco Brands, Inc. Process for making a nutritional bar
US4871550A (en) * 1986-09-05 1989-10-03 Millman Phillip L Nutrient composition for athletes and method of making and using the same
US5132113A (en) * 1990-10-26 1992-07-21 Maurizio Luca Nutritional composition containing essential amino acids
US5215750A (en) * 1991-09-04 1993-06-01 Keane Ii Michael A L-glutamine and vitamin-containing compositions effective for inducing weight loss and for weight control
CA2078019C (en) * 1991-09-13 2002-08-27 Siegbert Heinrich Bissbort Substance or composition and uses thereof
US5480865A (en) * 1994-02-25 1996-01-02 Parkinson's Charitable Trust Nutritional composition
GB9416921D0 (en) * 1994-08-22 1994-10-12 Conway Gitta C A nutritional preparation
US5817329A (en) * 1997-02-28 1998-10-06 Gardiner; Paul T. Nutritional supplement for increased muscle size and strength for body builders

Also Published As

Publication number Publication date
JP2001510145A (ja) 2001-07-31
DE69829853D1 (de) 2005-05-25
EP0891719A1 (de) 1999-01-20
DE69829853T2 (de) 2006-03-02
AU8465898A (en) 1999-02-10
EP1001685A1 (de) 2000-05-24
US6544547B2 (en) 2003-04-08
DK1001685T3 (da) 2005-08-08
EP1001685B1 (de) 2005-04-20
WO1999003365A1 (en) 1999-01-28
US20020142025A1 (en) 2002-10-03
HK1028324A1 (en) 2001-02-16

Similar Documents

Publication Publication Date Title
DE69829853D1 (de) Nahrungszusammensetzungen enthaltend methionin
CY1108033T1 (el) Βελτιωμενη παιδιατρικη συνθεση και μεθοδοι για την παροχη τροφης και τη βελτιωση της ανεκτικοτητος
NO990940L (no) Ernµringssammensetning for fenylketonuripasienter
DE69124223T2 (de) Vitamine und mineralien enthaltende nahrungszusätze
WO2002043507A3 (en) Nutrient supplements and methods for treating autism and for preventing the onset of autism
MXPA02007466A (es) Suplemento alimenticio a base de acido alfa-lipoico para incrementar la masa muscular escas y la fuerza.
ES2189427T3 (es) Productos nutricional para una persona que tiene fallo renal.
PT969744E (pt) Composicao nutritiva para melhorar a capacidade energetica celular
DE69806820D1 (de) Kaloriereiche ernährungszusammensetzung
ID28598A (id) Komposisi-komposisi yang mengandung vitamin-vitamin yang dapat larut lemak
BR0308713A (pt) Co-esférula de dha e alecrim, e métodos de uso
CY1108138T1 (el) Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι
CA2456519A1 (en) Oral compositions for the treatment of scalp disorders
AU2003214059A1 (en) Preparations containing folic acid, vitamin b6, and vitamin b12, and use thereof
WO2001091769A3 (en) Compositions for enhancing therapeutic effects containing herbals and/or nutritional supplements and/or minerals and/or vitamins
ZA885372B (en) Nutrieut mixture intended for the elderly
CA2285490A1 (en) Composition for improvement of cellular nutrition and mitochondrial energetics
PT971879E (pt) Composicoes solidas adequadas para administracao oral compreendendo l-carnitino e alcanoil.l.carnitino tartarato de magnesio
MY134893A (en) Dietary supplementation with, and methods for preparation of yeast- derived selenium salts
HK1036203A1 (en) Food supplements comprising lipoic acid and creatine and methods for their use
HUP0302294A2 (hu) L-karnitin és alkanoil-L-karnitin taurin-kloriddal és glicin-kloriddal alkotott nem higroszkópos sói és ezeket tartalmazó, orális beadásra alkalmas szilárd készítmények
DE69802789D1 (de) Feste zusammensetzungen für orale verabreichung die nicht-hygroskopische salze von l-carnitin-oder alkanoyl-l-carnitin mit 2-aminosulfonsäure enthalten
NO993678L (no) Fôr for salmonider
ATE493138T1 (de) Verbesserung der eisenaufnahme
WO2005009143A3 (fr) Produits alimentaires titres en fluor et leur utilisation pour assurer un developpement osseux harmonieux.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1001685

Country of ref document: EP